All Stories

  1. Mucocutaneous-onset Behçet’s disease: distinct early patterns, distinct long-term risks
  2. Gait Characteristics in Children with Juvenile Idiopathic Arthritis and Secondary Scoliosis
  3. DNA methylation profiling reveals distinct epigenetic clusters and suggests epigenetic patterns associated with sex and disease activity in childhood‐onset lupus
  4. Cutaneous manifestations of autoinflammatory bone diseases: a retrospective multicenter study
  5. Qualitative study on ethics in paediatric Systemic Inflammatory Response Syndrome (SIRS) research: perspectives of Turkish legal guardians
  6. Diagnostic Challenges in Pediatric Fever of Unknown Origin: Combined Role of Ferritin and Fever Duration
  7. Exploring pediatric onset Still’s disease patient journey and parental perceptions in Türkiye through a survey
  8. Predictors of damage accrual in childhood-onset SLE: a retrospective analysis from a tertiary lupus centre in Türkiye
  9. Syndrome of undifferentiated recurrent fever (SURF): a multicenter real-world experience from Türkiye
  10. Mevalonate kinase deficiency in a familial Mediterranean fever endemic region: a single-center experience
  11. The Effect of Secondary Prophylaxis Adherence on Rheumatic Heart Disease and Determinants of Poor Adherence in Children: A 10‐Year Retrospective Cohort Study
  12. The long-term follow up of patients with oligoarticular juvenile idiopathic arthritis: a single center experience.
  13. Results of a Nationwide Multicenter Study in Childhood Sjögren Disease
  14. Who Will Care for Our Children? Understanding the Lower Preference Rates for Pediatrics in Türkiye
  15. Gamified Telerehabilitation in Oligoarticular Juvenile Idiopathic Arthritis: A Randomized Controlled, Single‐Blind Trial
  16. Patients With IgA Vasculitis and Kawasaki Disease Show Dysregulated Interferon Signature
  17. Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force
  18. The day that belongs to children
  19. Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review
  20. Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study
  21. The Efficacy and Safety of Hepatitis A Vaccine in Children and Young Adults With an Autoinflammatory Diseases on Canakinumab and Tocilizumab Treatments: A Prospective Observational Controlled Study
  22. A rare association of osteogenesis imperfecta and juvenile idiopathic arthritis: case reports and literature review
  23. Fertility, pregnancy outcomes, and disease activity during pregnancy in patients with juvenile idiopathic arthritis: a descriptive study
  24. Autoinflammatory Bone Diseases
  25. Effects of dual-task exercises on cognitive status, disease activity and quality of life in childhood-onset systemic lupus erythematosus
  26. Glucocorticoid tapering early in the course of juvenile SLE: association with lupus low disease activity state and outcomes
  27. Interplay of NF-κB and PPAR-γ transcription factors in patients with juvenile systemic lupus erythematosus
  28. Differences and Similarities Between Children and Adults With Rhupus Syndrome
  29. miR-21 and cathepsin B in familial Mediterranean fever: novel findings regarding their impact on disease severity
  30. Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals
  31. Clinical course of paediatric-onset Behçet’s disease in young adulthood
  32. Children and Peace
  33. Interleukin (IL)-1/IL-6-Inhibitor–Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses
  34. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
  35. A rare disease with many faces: a multicentre registry of IgG4-related disease in children
  36. Juvenile Behçet syndrome: a contemporary view and differential diagnosis in pediatric practice
  37. Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis
  38. Measuring Transition Readiness of Patients After Transfer from Pediatric to Adult Care in Rheumatology
  39. Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosus
  40. Rare Turner syndrome and lupus coexistence with insights from DNA methylation patterns
  41. Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study
  42. Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: Risk factors for Hashimoto’s thyroiditis
  43. Rapid Drug Desensitization and Management of Breakthrough Reactions in Pediatric Patients
  44. The Impact of Different MEFV Genotypes on Clinical Phenotype of Patients with Familial Mediterranean Fever: Special Emphasis on Joint Involvement
  45. Long-term safety profile and secondary effectiveness of canakinumab in pediatric rheumatic diseases: a single-center experience
  46. Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient Cohort
  47. Childhood-onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations
  48. The emerging paradigm in pediatric rheumatology: harnessing the power of artificial intelligence
  49. Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registry
  50. Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis
  51. Health conditions of first-degree relatives of children with familial Mediterranean fever
  52. Description of the characteristics of the nailfold capillary structure in healthy children: a multi-centric study
  53. The effects of improvement in upper extremity function on gait and balance in children with upper extremity affected
  54. Examination of cardiac functions during acute attack and remission period in children with familial Mediterranean fever
  55. IS SCOLIOSIS A COMMON DEFORMITY IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS?
  56. Influenza vaccine uptake in juvenile idiopathic arthritis: a multi-centre cross-sectional study
  57. Unveiling Cardiac Involvement in Juvenile Dermatomyositis Through Speckle-Tracking Echocardiography
  58. Correction to: Validation of the PEDiatric Behçet’s Disease classification criteria: an evidence-based approach
  59. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy
  60. Artificial Intelligence in Pediatrics: Learning to Walk Together
  61. Exploring cardiovascular implications of juvenile dermatomyositis: Insights from aortic stiffness analysis and 3D echocardiography
  62. Rhupus syndrome in children: A multi-center retrospective cohort study and literature review
  63. Temporary Thyroid Dysfunction and Catecholamine Excess Due to Mercury Poisoning in 6 Cases
  64. Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study
  65. Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus
  66. Validation of the PEDiatric Behçet’s Disease classification criteria: an evidence-based approach
  67. Poverty and Discrimination: Big Enemies of Children All Over the World
  68. Gray zone in the spectrum of autoinflammatory diseases: familial Mediterranean fever accompanying periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: single-center experience
  69. Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings
  70. Exercise programs for scoliosis in juvenile idiopathic arthritis: a randomized-controlled study
  71. Ovarian reserve in children with juvenile idiopathic arthritis using biologic disease-modifying anti-rheumatic drugs
  72. Welcome to the New Issue (Vol: 29, No: 3, 2023) and Current News of the European Journal of Therapeutics
  73. Retrospective analysis of children diagnosed with Kawasaki disease
  74. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study
  75. The efficacy of a single-dose anakinra injection during disease attack in pediatric familial Mediterranean fever
  76. Juvenile and adult-onset scleroderma: Different clinical phenotypes
  77. POS0141 APPLICATION OF CRISS SCORE, REVISED CRISS SCORE AND RCID SCORE IN PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS
  78. AB1696 COMPARISON OF THE EFFECTIVENESS OF THE PERSONALIZED SCHROTH EXERCISE AND CONVENTIONAL THERAPY FOR SCOLIOSIS IN CHILDREN WITH RHEUMATIC DISEASE
  79. AB1419 IS DECREASED BODY MASS INDEX -2 Z SCORE OR LESS CORRELATING WITH AN ORGAN INVOLVEMENT PATTERN? RESULTS FROM THE JUVENILE SCLERODERMA INCEPTION COHORT
  80. POS0740 VALIDATION OF THE PEDIATRIC BEHÇET DISEASE CRITERIA (PEDBD): A REAL LIFE CONSENSUS-BASED APPROACH
  81. POS0139 DIFFUSE JUVENILE SYSTEMIC SCLEROSIS PATIENTS SHOW DISTINCT ORGAN INVOLVEMENT, ANTIBODY PATTERN AND HAVE SIGNIFICANTLY MORE SEVERE DISEASE IN THE LARGEST JSSC COHORT OF THE WORLD. RESULTS FROM THE JUVENILE SCLERODERMA INCEPTION COHORT
  82. POS0140 PATIENT AND PHYSICIAN REPORTED OUTCOMES OF JUVENILE SYSTEMIC SCLEROSIS PATIENTS SIGNIFICANTLY IMPROVE OVER 24 MONTHS OBSERVATION PERIOD IN THE JUVENILE SYSTEMIC SCLERODERMA INCEPTION COHORT
  83. A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry
  84. International cohort of 382 children with lupus nephritis – presentation, treatment and outcome at 24 months
  85. Type I Interferonopathies in Childhood
  86. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination
  87. Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis
  88. Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study
  89. Non-Rheumatic Chronic Comorbidities in Children with Juvenile Idiopathic Arthritis
  90. Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study
  91. Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: the TURSIS study
  92. Reply to comment by Kao et al on “An overview of the relationship between juvenile idiopathic arthritis and potential environmental risk factors: Do early childhood habits or habitat play a role in the affair?”
  93. Data‐Driven Magnetic Resonance Imaging Definitions for Active and Structural Sacroiliac Joint Lesions in Juvenile Spondyloarthritis Typical of Axial Disease: A Cross‐Sectional International Study
  94. Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial
  95. Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohort
  96. Monitoring of Antibody Levels Following SARS-CoV-2 Infection in Children and Late Adolescents with Inflammatory Rheumatic Diseases
  97. Pediatric Takayasu Arteritis: A Review of the Literature
  98. Child Brides and Forced Marriages: An Aspect of Child Abuse and Neglect
  99. The role of S100A12 and Toll‐like receptor 4 in assessment of disease activity in familial Mediterranean fever and juvenile idiopathic arthritis
  100. How to Prepare Our Research for Publication in Medical Journals?
  101. Long-term efficacy of tonsillectomy/adenotonsillectomy in patients with periodic fever aphthous stomatitis pharyngitis adenitis syndrome with special emphasis on co-existence of familial Mediterranean fever
  102. A cursed goodbye kiss from severe acute respiratory syndrome-coronavirus-2 to its pediatric hosts: multisystem inflammatory syndrome in children
  103. NLRP3 gene variants and serum NLRP3 levels in periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome
  104. Editorial: COVID-19 and hyper inflammation syndrome: Different presentation and management
  105. An overview of the relationship between juvenile idiopathic arthritis and potential environmental risk factors: Do early childhood habits or habitat play a role in the affair?
  106. Case–control study of corneal topography and specular microscopy parameters in JIA patients with and without ocular involvement
  107. Increased Frequency of Febrile Seizures in Two Periodic Fever Syndromes: Familial Mediterranean Fever and PFAPA Syndrome
  108. Assessment of myelin oligodendrocyte glycoprotein antibodies and magnetic resonance spectroscopy in childhood-onset systemic lupus erythematosus
  109. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort
  110. An evaluation of sleep habits and childhood-onset systemic lupus erythematosus
  111. Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever
  112. Assessment of Surrogate Markers for Cardiovascular Disease in Familial Mediterranean Fever-Related Amyloidosis Patients Homozygous for M694V Mutation in MEFV Gene
  113. A case of juvenile systemic sclerosis and congenital pulmonary airway malformation related mucinous adenocarcinoma of the lung: paraneoplastic syndrome or just a coincidence?
  114. Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children
  115. COVID-19 Vaccination Practice of Children with Rheumatic Disease: A Survey-based Study
  116. Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis
  117. Anti-Racist Pediatric Research Against Discrimination in Science with Diversity, Equity, and Inclusion
  118. Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective
  119. A preliminary study: relationship between inattention/hyperactivity and familial mediterranean fever in children and adolescents
  120. Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis
  121. Rare coexistence in pediatric practice: Hereditary angioedema and familial mediterranean fever
  122. Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel
  123. Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children
  124. International Consensus for the Dosing of Corticosteroids in Childhood‐Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis
  125. Early experience of COVID‐19 vaccine‐related adverse events among adolescents and young adults with rheumatic diseases: A single‐center study
  126. Evaluation of plasma carnitine status in patients diagnosed with juvenile idiopathic arthritis
  127. Juvenile spondyloartropathies
  128. Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome: A Single-Center Experience
  129. Specific early signs and long-term follow-up findings of progressive pseudorheumatoid dysplasia (PPRD) in the Turkish cohort
  130. Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis
  131. A fatal interstitial lung disease in an anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody negative patient with juvenile dermatomyositis
  132. Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis
  133. Insulin resistance in children with juvenile systemic lupus erythematosus and ınvestigation of the possibly responsible factors
  134. Telemedicine Applications in a Tertiary Pediatric Hospital in Turkey During COVID-19 Pandemic
  135. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study
  136. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study
  137. Evaluation of the Serum Visfatin and Adiponectin Levels Related with the Activity of Juvenile Idiopathic Arthritis
  138. Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER
  139. Validity and reliability of “Shriners Hospital for Children Upper Extremity Evaluation” in children with rheumatic diseases
  140. Caregiver burden and related factors in caregivers of patients with childhood-onset systemic lupus erythematosus
  141. Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients
  142. Anti‐nuclear antibody testing in children: How much is really necessary?
  143. A Big Problem and Debate in COVID-19 Pandemics: Equitable and Effective Access of the COVID-19 Vaccines and Waiver of Intellectual Property
  144. A Novel and Severe Clinical Picture Related to COVID-19: Multi-Inflammatory Syndrome in Children
  145. Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders
  146. Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children
  147. POS1320 DIFFERENCES IN CLINICAL MANIFESTATION AND DISEASE ACTIVITY OF PEDIATRIC BEHÇET DISEASE: A CROSS-SECTIONAL COHORT COMPARISON BETWEEN TURKEY AND UNITED STATES
  148. LB0004 EFFICACY AND SAFETY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS: PRIMARY RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA)
  149. POS1304 JUVENILE SYSTEMIC SCLEROSIS (JSSC) PATIENTS WITH OVERLAP CHARACTERISTICS DO NOT HAVE MILD DISEASE. RESULTS FROM THE JSSC INCEPTION COHORT. WWW.JUVENILESCLERODERMA.COM
  150. POS0079 PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS HAVE A DISTINCT PATTERN OF ORGAN INVOLVEMENT.RESULTS FROM THE JUVENILE SYSTEMIC SCLEROSIS INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM
  151. POS1375 THE EFFECT OF M694V HOMOZYGOSITY ON THE CAROTID INTIMA-MEDIA THICKNESS AND FLOW MEDIATED DILATATION IN PATIENTS WITH FMF RELATED AMYLOIDOSIS
  152. Pediatric Behçet's Disease
  153. Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey
  154. Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents
  155. A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C)
  156. SARS-CoV-2 infection in children and the Turkish Archives of Pediatrics
  157. Systolic and Diastolic Cardiac Functions in Juvenile Spondyloarthropathies
  158. Effects of sense and functionality changes in the hands on activity and participation in patients with juvenile scleroderma
  159. Consensus-based recommendations for the management of juvenile systemic sclerosis
  160. Tocilizumab therapy in juvenile systemic sclerosis: a retrospective single centre pilot study
  161. Independent risk factors for resolution of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome within 4 years after the disease onset
  162. The role of Mediterranean fever gene variants in patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome
  163. Evaluation of the thyroid disorders in children with familial Mediterranean fever
  164. Unexpected increase of aortic stiffness in juvenile Spondyloarthropathies
  165. Vitamin D binding protein genotype frequency in familial Mediterranean fever patients
  166. Decreased frequency of allergy in juvenile idiopathic arthritis: Results of a case-control study
  167. Comment on: The conundrum of juvenile spondyloarthritis classification: Many names for a single disease? Lesson learned from an instructive clinical case
  168. Increased frequency of sleep problems in children and adolescents with familial Mediterranean fever: The role of anxiety and depression
  169. Determination of tuberculin skin test for isoniazid prophylaxis in BCG vaccinated children who are using anti‐TNF agents for rheumatologic diseases
  170. A controversial topic in juvenile idiopathic arthritis: Association between biologic agents and malignancy
  171. Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review
  172. Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic
  173. Epstein–Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity
  174. Biologics in Juvenile Idiopathic Arthritis-Main Advantages and Major Challenges: A Narrative Review
  175. Evaluation of Health Status of Children with Autoinflammatory Diseases During COVID-19 Pandemic
  176. THU0308 COMPARISON OF CHILDHOOD-ONSET VERSUS ADULT-ONSET TAKAYASU ARTERITIS: A STUDY OF 141 PATIENTS FROM TURKEY
  177. SAT0500 HOW THE ADULT CRISS WORKS IN PEDIATRIC jSSc PATIENTS - RESULTS FROM THE JUVENILE SCLERODERMA INCEPTION COHORT
  178. THU0499 IS THERE A DIFFERENT PRESENTATION OF JUVENILE SYSTEMIC DIFFUSE AND LIMITED SUBSET? DATA FROM THE JUVENILE SCLERODERMA INCEPTION COHORT. WWW.JUVENILE-SCLEORDERMA.COM
  179. FRI0455 IS THERE AN INCREASE IN THE FREQUENCY OF INFLAMMATORY DISEASES IN THE FAMILIES OF PATIENTS WITH FMF?
  180. AB1011 LONG TERM FOLLOW-UP of THE PATIENTS WITH ANTI NUCLEAR ANTIBODY POSITIVITY WHO HAD INITIALLY NO IDENTIFIABLE RHEUMATIC DISEASES
  181. FRI0466 NO DISEASE PROGRESSION AFTER 36 MONTHS FOLLOW UP IN THE JUVENILE SYSTEMIC SCLERODERMA INCEPTION COHORT
  182. SAT0503 SERIOUS INFECTION RISK IN PEDIATRIC PATIENTS WITH LOW IMMUNOGLOBULIN LEVELS FOLLOWING RITUXIMAB TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) OR MICROSCOPIC POLYANGIITIS (MPA)
  183. AB1325-HPR THE TRANSITION FROM PEDIATRIC TO ADULT RHEUMATOLOGY OF 347 PATIENTS AT A SINGLE CENTER
  184. FRI0454 UNDER DETECTION OF INTERSTITIAL LUNG DISEASE IN JUVENILE SYSTEMIC SCLEROSIS (JSSC) UTILIZING PULMONARY FUNCTION TESTS. RESULTS FROM THE JUVENILE SCLERODERMA INCEPTION COHORT
  185. Autoinflammatory Diseases in Childhood
  186. Mercury intoxication resembling pediatric rheumatic diseases: case series and literature review
  187. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
  188. Screening for Fabry Disease in Patients With Juvenile Systemic Lupus Erythematosus
  189. Screening for Latent Tuberculosis in Children With Immune-Mediated Inflammatory Diseases Treated With Anti-Tumor Necrosis Factor Therapy: Comparison of Tuberculin Skin and T-SPOT Tuberculosis Tests
  190. Pediatric Behçet’s disease - clinical aspects and current concepts
  191. Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection
  192. A monogenic autoinflammatory disease with fatal vasculitis
  193. Science and pseudoscience during the COVID-19 pandemic
  194. Scientific researches and academic publishing during the coronavirus pandemic
  195. Serum KL-6 level as a biomarker of interstitial lung disease in childhood connective tissue diseases: a pilot study
  196. Evaluation of co-existing diseases in children with familial Mediterranean fever
  197. Performance of recently proposed periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome criteria in a region endemic for familial Mediterranean fever
  198. Serological screening for celiac disease in children with systemic lupus erythematosus
  199. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single‐center experience
  200. Superb Microvascular Imaging Compared With Power Doppler Ultrasound in Assessing Synovitis of the Knee in Juvenile Idiopathic Arthritis: A Preliminary Study
  201. Serological screening for coeliac disease in patients with juvenile idiopathic arthritis
  202. Serological Evidence of Tick-Borne Encephalitis and West Nile Virus Infections Among Children with Arthritis in Turkey
  203. SAT0478 AFTER 24 MONTHS OBSERVATION PERIOD THE PATIENTS RELATED OUTCOMES IMPROVE SIGNIFICANTLY IN THE JUVENILE SCLERODERMA INCEPTIONS COHORT. WWW.JUVENILE-SCLERODERMA.COM
  204. FRI0573 COGNITIVE IMPAIRMENT IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: EARLY DETECTION WITH MR SPECTROSCOPY AND ITS ASSOCIATION WITH MOG ANTIBODIES
  205. SAT0503 DEVELOPMENT OF MALIGNANCIES IN JIA PATIENTS EXPOSED TO BIOLOGIC AGENTS:A SINGLE CENTRE RETROSPECTIVE STUDY
  206. SAT0523 EVALUATION OF COEXISTING DISEASES IN CHILDREN WITH FAMILIAL MEDITERRANEAN FEVER
  207. AB0924 EVALUATION OF PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS AND JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS
  208. AB0992 HEPATITIS A VIRUSVACCINATION IN AUTOINFLAMMATORY DISEASES UNDER CANAKINUMAB AND TOCILIZUMAB TREATMENT
  209. AB0967 IS THERE A DIFFERENCE IN PRESENTATION OF FEMALE AND MALE PATIENTS WITH JUVENILE SYSTEMIC SCLERODERMA. AN UPDATE FROM THE JUVENILE SYSTEMIC SCLERODERMA INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM
  210. AB0926 JUVENILE SYSTEMIC SCLEROSIS AND MUCINOUS ADENOCARCINOMA OF THE LUNG IN PATIENT WITH CYSTIC ADENOID MALFORMATION-PARANEOPLASTIC SYNDROME OR JUST A COINCIDENCE?
  211. OP0205 LIVE ATTENUATED VACCINES IN PEDIATRIC RHEUMATIC DISEASES ARE SAFE: MULTICENTER, RETROSPECTIVE DATA COLLECTION
  212. FRI0538 MAY SOME OF THE MEFV GENE VARIANTS CAUSE PFAPA SYNDROME LIKE SYMPTOMS?
  213. FRI0552 PERFORMANCE OF NEWLY PROPOSED PERIODIC FEVER, APHTHOUS STOMATITIS, PHARYNGITIS AND CERVICAL ADENITIS (PFAPA) SYNDROME CRITERIA IN REGIONS ENDEMIC FOR FAMILLIAL MEDITERRANEAN FEVER (FMF)
  214. AB1041 PREVALENCE OF JUVENILE IDIOPATHIC ARTHRITIS (JIA) SUBGROUPS AND JIA-ASSOCIATED UVEITIS AMONG JIA PATIENTS ADMITTED TO REFERRAL PEDIATRIC RHEUMATOLOGY CLINICS IN TURKEY: A RETROSPECTIVE STUDY, JUPITER
  215. AB0966 PROPOSAL OF OUTCOME MEASURES TO BE USED ON A 12-MONTH OPEN LABEL DRUG TRIAL IN JUVENILE SYSTEMIC SCLEROSIS. RESULTS OF THE 3RD CONSENSUS MEETING IN HAMBURG DECEMBER 2018
  216. AB0927 SUPERB MICROVASCULAR IMAGING COMPARED WITH POWER DOPPLER ULTRASOUND IN ASSESSING SYNOVITIS OF THE KNEE IN JUVENILE IDIOPATHIC ARTHRITIS: A PRELIMINARY STUDY
  217. THU0726B-HPR THE FACTORS AFFECTING HANDWRITING SPEED IN PATIENTS WHO HAVE AN AFFECTED WRIST JOINT WITH OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
  218. AB1363-HPR THE INVESTIGATION OF THE QUALITY OF LIFE AND FUNCTIONAL ABILITIES IN PATIENTS WITH JUVENILE SCLERODERMA
  219. FRI0705-HPR THE RELATIONSHIP BETWEEN SELF-REPORTED PAIN EXPERIENCE AND FUNCTIONALITY IN PATIENTS WITH JUVENILE SCLERODERMA
  220. AB0925 TOCILIZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS
  221. SAT0479 UPDATE FROM THE JUVENILE SCLERODERMA INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM
  222. Leap Motion Controller–based training for upper extremity rehabilitation in children and adolescents with physical disabilities: A randomized controlled trial
  223. Anaphylactic reaction to anakinra in a child with steroid-dependent idiopathic recurrent pericarditis and successful management with canakinumab
  224. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
  225. Correction to: Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study
  226. Consensus-based recommendations for the management of juvenile localised scleroderma
  227. Spectrum of the neurologic manifestations in childhood-onset cryopyrin-associated periodic syndrome
  228. Effects of Video Games–Based Task-Oriented Activity Training (Xbox 360 Kinect) on Activity Performance and Participation in Patients With Juvenile Idiopathic Arthritis
  229. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study
  230. Fatigue and sleep in children and adolescents with juvenile idiopathic arthritis:a cross-sectional study
  231. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α
  232. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis
  233. Pediatric rheumatology in Turkey
  234. Hepatitis A virus vaccination in childhood-onset systemic lupus erythematosus
  235. Tuberculin skin test response in patients with juvenile idiopathic arthritis on anti-TNF therapy
  236. The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study
  237. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center
  238. Evaluation of six-minute walk test in juvenile systemic sclerosis
  239. Juvenile Scleroderma-What has Changed in the Meantime?
  240. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials
  241. Juvenile Scleroderma: A Referral Center Experience
  242. Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort
  243. Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences
  244. Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus
  245. The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis
  246. SEROLOGICAL SCREENING FOR CELIAC DISEASE IN CHILDREN WITH COLCHICINE-RESISTANT FAMILIAL MEDITERRANEAN FEVER
  247. FRI0005 The relationship between juvenile systemic lupus erythematosus and the transcription factors nf-kappab and ppar-gamma
  248. AB0764 Comparison of disease characteristics in patients with juvenile-onset and adult-onset progressive systemic sclerosis
  249. THU0740-HPR Determination of exercise behaviour in patients with juvenile idiopathic arthritis
  250. THU0577 Do raynaud phenomenon negative juvenile systemic scleroderma patients have a different pattern of organ involvement as raynaud phenomenon positive patients?
  251. THU0558 Increased frequency of febrile seizures in two periodic fever syndromes: familial mediterranean fever and pfapa syndrome
  252. AB1080 Neurological evaluation of childhood-onset cryopyrin-asscociated periodic syndromes-a preliminary report
  253. OP0332 Paediatric open-label clinical study of rituximab for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)
  254. FRI0496 Polyarteritis nodosa: over 20 years' clinical experience
  255. FRI0722-HPR Postural problems and pain in patients with juvenile idiopathic arthritis
  256. THU0268 The frequency of juvenile spondyloarthropathies in childhood famillial mediterranean fever
  257. THU0559 The performance of the newly proposed eular/acr classification criteria in juvenile-onset systemic lupus erythematosus-a preliminary study
  258. AB1079 Transition care of patients with childhood onset chronic rheumatic disease in a tertiary medical centre in turkey
  259. THU0005 Whole genome linkage and exome sequencing analyses in takayasu arteritis families
  260. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
  261. Comparison of Familial Mediterranean Fever and juvenile idiopathic arthritis patients according to family origin
  262. LACC1 Gene Defects in Familial Form of Juvenile Arthritis
  263. The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
  264. The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey
  265. Genotype-phenotype investigation of 35 patients from 11 unrelated families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome
  266. Mucolipidosis type III gamma: Three novel mutation and genotype-phenotype study in eleven patients
  267. PFAPA Syndrome in a Population with Endemic Familial Mediterranean Fever
  268. Comparison of Early-Onset and Late-Onset Pediatric Systemic Lupus Erythematosus
  269. Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome
  270. Role of genetics in pediatric rheumatology
  271. The performance of classification criteria for juvenile spondyloarthropathies
  272. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
  273. New Insights into Cardiac Involvement in Juvenile Scleroderma: A Three-Dimensional Echocardiographic Assessment Unveils Subclinical Ventricle Dysfunction
  274. Familial Mediterranean fever in childhood: a single-center experience
  275. Emotional and behavioral influence of headache in Pediatric rheumatic diseases
  276. A Case of Kawasaki Disease with Initial Presentation of Arthritis and Icterus
  277. Evaluation of pulmonary artery pressure in patients with juvenile systemic lupus erythematosus (SLE)
  278. Deficiency of Complement 1r Subcomponent in Early-Onset Systemic Lupus Erythematosus: The Role of Disease-Modifying Alleles in a Monogenic Disease
  279. Erratum to: Evaluation of cardiac functions in juvenile systemic lupus erythematosus with two-dimensional speckle tracking echocardiography
  280. REST Final-Exon-Truncating Mutations Cause Hereditary Gingival Fibromatosis
  281. An Unusual Association of Pyoderma Gangrenosum with Henoch-Schonlein Purpura in a Child
  282. AB0994 Anti TNF-ALPHA therapy would be lifesaving in deficiency of adenosine deaminase-2
  283. OP0063 Canakinumab treatment in patients with colchicine-resistant FMF (CRFMF), HIDS/MKD and traps: efficacy in the 16 weeks randomised controlled phase and maintenance of disease control and safety at week 40
  284. FRI0745-HPR Investigation of association between wrist pain, functional performance, grip and pinch strength in children and adolescents with juvenile idiopathic arthritis: cross-sectional study
  285. AB0957 Is there a difference in the clinical presentation of juvenile systemic scleroderma patients according the age of onset: results from the juvenile scleroderma inception cohort www.juvenile-scleroderma.com
  286. THU0498 Pfapa syndrome in large pediatric population: a single center experience
  287. SAT0766-HPR The factors affecting functional abilities in patients with juvenile idiopathic arthritis
  288. FRI0746-HPR The factors affecting stair climbing in patients who have an affected knee joint with oligoarticular juvenile idiopathic arthritis
  289. Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up – CORRIGENDUM
  290. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency
  291. The impact of peer victimization and psychological symptoms on quality of life in children and adolescents with systemic lupus erythematosus
  292. Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up
  293. Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey
  294. Juvenile Idiopathic Arthritis
  295. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus
  296. The frequency of the celiac disease among children with familial Mediterranean fever
  297. Juvenile dermatomyositis: a tertiary center experience
  298. Idiopathic Pulmonary Hemosiderosis in a Child with Recurrent Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis
  299. Successful Hyperbaric Oxygen Treatment of Gangrenous Lesions due to Systemic Lupus Erythematosus
  300. TNF-alpha 863C > A promoter and TNFRII 196T > G exonic variationsmay be risk factors for juvenile idiopathic arthritis
  301. Sjögren’s syndrome associated with systemic lupus erythematosus
  302. Cardiac involvement in juvenile idiopathic arthritis
  303. Juvenile Spondyloarthropathies
  304. Potential of Serum and Urinary Matrix Metalloproteinase-9 Levels for the Early Detection of Renal Involvement in Children With Henoch-Schönlein Purpura
  305. SAT0258 Assessing Myocardial Deformation of Kawasaki Patients with Speckle-Tracking Echocardiography on Long Term Follow Up
  306. AB0885 Childhood-Onset Eosinophilic Granulomatosis with Polyangiitis: A Rare Childhood Vasculitis Mimicking Anthrax and Eosinophilic Leukemia
  307. THU0229 Is There A Difference in The Presentation of Diffuse and Limited Subtype in Childhood? Results from The Juvenile Scleroderma Inception Cohort
  308. THU0230 Is There A Difference in The Presentation of Male and Female Patients with Juvenile Systemic Sclerosis? Results from The Juvenile Scleroderma Inception Cohort
  309. SAT0254 The Iceberg in Juvenile Onset Systemic Lupus Erythematosus: Subclinical Deterioration of Cardiac Functions Assessed with Two-Dimensional Speckle Tracking Echocardiography and Contributing Factors of Systolic Dysfunction
  310. THU0223 Demographic and Clinical Characteristics of Patients with Juvenile Scleroderma-A Single Center Experience
  311. THU0224 Pulmonary Arterial Hypertension in Patients with Juvenile Lupus Erythematosus
  312. SAT0257 Update on The Juvenile Systemic Sclerosis Inception Cohort Project. Characteristics of The First 74 Patients at First Assessment
  313. Hyperimmunoglobulinaemia D syndrome: a rare cause of prolonged fever and treatment with anti-interleukin 1 agent
  314. Evaluation of cardiac functions in juvenile systemic lupus erythematosus with two-dimensional speckle tracking echocardiography
  315. Vitamin D levels in children with familial Mediterranean fever
  316. Serum vitamin D levels during activation and remission periods of patients with juvenile idiopathic arthritis and familial Mediterranean fever
  317. Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever – a randomized controlled noninferiority trial
  318. Screening of Free Carnitine and Acylcarnitine Status in Children With Familial Mediterranean Fever
  319. Relationship between vitamin B12, homocysteine and oxidative stress in juvenile idiopathic arthritis
  320. Panniculitis in juvenile dermatomyositis: Report of a case and review of the published work
  321. Primary catastrophic antiphospholipid syndrome in an 8 year-old girl
  322. Childhood-onset eosinophilic granulomatosis with polyangiitis: a rare childhood vasculitis mimicking anthrax and eosinophilic leukaemia
  323. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collabo...
  324. Pediatric vasculitis
  325. Renovasküler Hipertansiyon İle Gelen Takayasu Arteritli Bir Olgu
  326. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
  327. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
  328. A Case of Acute Rheumatic Fever With Henoch Schonlein Purpura
  329. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD
  330. Screening Inherited Metabolic Disorders in Patients with Familial Mediterranean Fever
  331. Diagnostic approach and current treatment options in childhood vasculitis
  332. Evaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period
  333. Cost of Familial Mediterranean Fever (Fmf) Disease In Turkey
  334. How Pricing And Reimbursement Policies Affect The Budget Impact of The Treatment of Systemic Juvenile Idiopathic Arthritis In Turkey
  335. Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
  336. Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
  337. Pathological and immunological features of autoinflammatory syndrome associated with lymphedema (AISLE)
  338. Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
  339. Turkish Pediatric Rheumatology Society consensus statements on systemic onset juvenile idiopathic arthritis in Turkey
  340. Achromobacter causing a thrombophlebitis and osteomyelitis combination: a rare cause: Figure 1
  341. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
  342. Chronic recurrent multifocal osteomyelitis: a rare skeletal disorder
  343. The frequency of pulmonary hypertension in patients with juvenile scleroderma
  344. A difficult case of Hodgkin Lymphoma with differential diagnosis of tuberculosis and sarcoidosis
  345. Effect of Strengthening Versus Balance-Proprioceptive Exercises on Lower Extremity Function in Patients with Juvenile Idiopathic Arthritis
  346. THU0637-HPR Cross-Cultural Adaptation, Reliability, and Validity of the Turkish Version of Pedsql Multidimensional Fatigue Scale: A Fatique for Children and Adolesant S with Arthritis in Turkey
  347. AB0968 Adrenomedullin Levels in Patients with Familial Mediterranean Fever: A Long Term Follow-Up
  348. AB1007 Determination of Free Carnitine and Acyl-Carnitine Status of Patients with Juvenile Idiopathic Arthritis
  349. FRI0616-HPR Fatigue, Quality of Sleep and Pain in Children with Juvenile Idiopathic Arthritis
  350. THU0525 Juvenile Spondyloarthropathies: A Single Center Experience
  351. AB1008 Screening of Free Carnitine and Acyl-Carnitine Status in Patients with Familial Mediterranean Fever
  352. AB1006 Serum Vitamin D Levels During Activation and Remission Periods of Patients with Juvenile Idiopathic Arthritis and Familial Mediterranean Fever
  353. AB1241-HPR Static and Dynamic Pedobarographic Assessment in Patients with Juvenile Idiopathic Arthritis
  354. AB0979 The Distribution of JIA Subtypes and Evaluation of the Disease Status in Turkey
  355. Biological Agents in Familial Mediterranean Fever Focusing on Colchicine Resistance and Amyloidosis
  356. Treatment in juvenile rheumatoid arthritis and new treatment options
  357. Canakinumab: new treatment choice for systemic juvenile idiopathic arthritis
  358. Abdominal pain developing from a polyarteritis nodosa-induced hepatic aneurysm
  359. Acute granulomatous iridocyclitis in a child with tubulointerstitial nephritis and uveitis syndrome
  360. Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis
  361. Familial Mediterranean Fever in childhood: a single center experience
  362. Articular involvement in childhood Familial Mediterranean Fever
  363. A case of systemic juvenile idiopathic arthritis with pulmonary hemosiderosis secondary to recurrent macrophage activation syndrome or a new autoinflammatory syndrome?
  364. Developing of a new scale for assessing the adherence to colchicine treatment in pediatric patients with FMF
  365. Development of focal segmental glomerulosclerosis in a patient with Familial Mediterranean Fever resistant to colchicine therapy under treatment with Canakinumab
  366. Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
  367. Screening of free carnitine and acyl-carnitine status in patients with Familial Mediterranean Fever
  368. Primary headaches in pediatric patients with chronic rheumatic disease
  369. Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
  370. Association of familial Mediterranean fever in Turkish children with inflammatory bowel disease
  371. Use of tissue Doppler and its comparison with other pulse Doppler echocardiography in the evaluation of diastolic functions in patients with active juvenile idiopathic arthritis
  372. AB1045 Development and Validation of Juvenile Autoinflammatory Disease Multidimensional Assessment Report (JAIMAR)
  373. FRI0584-HPR Relationship between Pain and Functional Ability, Anxiety and Depression in Patients with Juvenile-Onset Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis
  374. AB1169-HPR The Relationship between Pain and Health-Related Quality of Life in Patients with Juvenile-Onset Systemic Lupus Erythematosus
  375. Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up
  376. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy
  377. Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy
  378. FMF50: a score for assessing outcome in familial Mediterranean fever
  379. CINCA syndrome in an infant presenting with hydrocephalus
  380. The new proposal classification criteria for juvenile spondyloarthropathies
  381. Autoinflammatory diseases in childhood
  382. The frequency of pulmonary hypertension in juvenile scleroderma
  383. Regular Aerobic Training Combined with Range of Motion Exercises in Juvenile Idiopathic Arthritis
  384. Juvenile dermatomyositis: clinical features, laboratory findings, treatment modalities and disease course (a single center experience)
  385. Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
  386. Evaluation of ppd response in patients with idiopathic arthritis who are on biological drug therapy
  387. Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up
  388. Clinical presentations and molecular basis of complement C1R mutation in a large turkish family
  389. Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
  390. SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis
  391. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration
  392. Severe digital necrosis in a 4-year-old boy: primary Raynaud's or jellyfish sting
  393. Sarcoidosis infantil. Un caso clínico infrecuente
  394. An unusual case of childhood sarcoidosis
  395. Tuberculous Meningitis in a Patient with Systemic Lupus Erythematosus
  396. DNASE1L3Mutations in Hypocomplementemic Urticarial Vasculitis Syndrome
  397. Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: Immunogenicity and safety?
  398. Multiple small hyperintense lesions in the subcortical white matter on cranial MR images in two Turkish brothers with cold-induced sweating syndrome caused by a novel missense mutation in the CRLF1 gene
  399. FRI0590-HPR Evaluation of gait in children with juvenile idiopathic arthritis
  400. Association of Inflammatory Bowel Disease With Familial Mediterranean Fever in Turkish Children
  401. Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood
  402. P01-016 – Decreased vitamin D levels in FMF patients
  403. P01-019 – Anti-CCP antibodies are not associated with FMF
  404. PW01-015 – Canakinumab in adults with colchicin resistant FMF
  405. PReS-FINAL-2097: Evaluation of gait in children with juvenile idiopathic arthritis
  406. PReS-FINAL-2042: Health-related quality of-life in Turkish children and adolescents with juvenile idiopathic arthritis
  407. Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
  408. Lupus nefritli bir olguda sistemik steroidlerin ender bir komplikasyonu: mediyastinal lipomatoz olgusu
  409. Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus
  410. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
  411. FRI0475-HPR Comparison the effect to the lower extremity functions of strengthening exercises and proprioceptive-balance exercises in juvenile idiopathic arthritis
  412. FRI0358 The association between inflammatory bowel diseases and familial mediterranean fever in turkish children diagnosed as familial mediterranean fever
  413. FRI0477-HPR The efficacy of land-based home exercise program in patients with juvenile idiopathic arthritis: A randomized-controlled, single-blind study
  414. Cross-cultural adaptation, reliability, and validity of the Turkish version of PedsQL 3.0 Arthritis Module: a quality-of-life measure for patients with juvenile idiopathic arthritis in Turkey
  415. T-CELL LYMPHOMA MASQUERADING AS JUVENILE RHEUMATOID ARTHRITIS
  416. TREATMENT OF ALLERGIC RHINITIS IN CHILDREN: WHAT'S NEW?
  417. Assesing the Effect of ANA Positivity on Clinical Picture of the Juvenile Idiopathic Arthritis in a Large Cohort of Turkish Ancestry
  418. Pneumococcal Vaccination in Juvenile Idiopathic Arthritis
  419. Efficacy of a land-based home exercise programme for patients with juvenile idiopathic arthritis: A randomized, controlled, single-blind study
  420. QT dispersion and cardiac involvement in children with Familial Mediterranean fever
  421. Clinical characteristics of pediatric-onset neuro-Behcet disease
  422. Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease?
  423. QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis
  424. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: An international multicenter PRINTO study
  425. The PRINTO provisional definition of remission in juvenile dermatomyositis
  426. The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis
  427. F213 THE RELATIONSHIP BETWEEN QUALITY OF LIFE AND PAIN IN JUVENILE IDIOPATHIC ARTHRITIS
  428. Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever
  429. Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?
  430. Increased expression of exon 2 deleted MEFV transcript in familial Mediterranean fever patients
  431. Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever
  432. Ergenlik çağında bağ dokusu hastalıkları
  433. Application of the new pediatric criteria and Tel Hashomer criteria in heterozygous patients with clinical features of FMF
  434. Dialysate CA125 levels after 5 years on continuous peritoneal dialysis
  435. QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis
  436. Influence of Reduced Folate Carrier and Aminoimidazole Carboxamide Ribonucleotide Transformylase gene polymorphisms on the efficacy of methotrexate in juvenile idiopathic arthritis
  437. Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus
  438. Turkish version of the pediatric quality of life inventory (PedsQL) 3.0 arthritis module: a reliability and validity study
  439. A pilot study for genome wide association study (GWAS) in patients with juvenile idiopathic arthritis (JIA) and their parents
  440. P wave dispersion and cardiac involvement in patients with juvenile idiopathic arthritis
  441. Effect of ANA positivity on clinical picture of the JIA: should ANA positive JIA be classified as a different group?
  442. Picture of the Month—Quiz Case
  443. Pelvic MRI findings of juvenile-onset ankylosing spondylitis
  444. Renovascular hypertension in a child with Marfan syndrome
  445. Classic polyarteritis nodosa presenting with acute anuric renal failure
  446. Eklem ağrısı ile başvuran çocukta ayırıcı tanı
  447. Do infections trigger juvenile idiopathic arthritis?
  448. Preliminary cross-cultural adaptation of a new pediatric health-related quality of life scale in children with systemic lupus erythematosus: an international effort
  449. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis
  450. Left ventricular function by ‘conventional’ and ‘tissue Doppler’ echocardiography in paediatric dialysis patients
  451. Purified Protein Derivative Response in Juvenile Idiopathic Arthritis
  452. Juvenile linear scleroderma with unique forms of renal involvement
  453. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood
  454. Retrospective analysis of children with uveitis treated with infliximab
  455. Infection Factors Which Have a Role in the Aetiopathogenesis of Primary and Exacerbation Juvenile Idiopathic Arthritis and the Relationship of Infection Factors with Procalcitonin Levels
  456. Progression of coronary calcification in pediatric chronic kidney disease stage 5
  457. Factors affecting survival in juvenile systemic sclerosis
  458. MEFV Mutations Modify the Clinical Presentation of Henoch-Schönlein Purpura
  459. Left ventricular systolic and diastolic function and carotid intima-media thickness in pediatric dialysis patients
  460. A Case of Catastrophic Antiphospholipid Syndrome in an Adolescent Girl With Parvovirus B19 Infection
  461. Dissection of the abdominal aorta in a child with takayasu's arteritis
  462. Depression, anxiety and pain in juvenile idiopathic arthritis
  463. Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
  464. Prevalence of the MEFV Gene Mutations in Childhood Polyarteritis Nodosa
  465. A Child With Primary Sjögren Syndrome and a Review of the Literature
  466. Is Familial Mediterranean Fever a thrombotic disease or not?
  467. Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients
  468. Juvenile idiopathic arthritis
  469. Coronary artery calcifications in children with end-stage renal disease
  470. Childhood vasculitides in Turkey: a nationwide survey
  471. Systemic lupus erythematosus due to Epstein–Barr virus or Epstein–Barr virus infection provocating acute exacerbation of systemic lupus erythematosus?
  472. Dialysate CA125 levels in children on continuous peritoneal dialysis
  473. Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia
  474. THE ANEMIA OF FAMILIAL MEDITERRANEAN FEVER DISEASE
  475. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set
  476. Familial Mediterranean Fever (FMF) in Turkey
  477. Albuminuria and tubular markers in juvenile idiopathic arthritis
  478. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
  479. Juvenile polyarteritis: Results of a multicenter survey of 110 children
  480. Hepatitis B vaccination in children with juvenile idiopathic arthritis
  481. Is there any relationship between Chlamydophila pneumoniae infection and juvenile idiopathic arthritis?
  482. The Role of Streptococcal Infection in Henoch-Schonlein Purpura
  483. Evaluation of classification criteria for juvenile-onset spondyloarthropathies
  484. Toxic hepatitis due to enalapril in childhood
  485. Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients
  486. Letter to editor
  487. MRI findings of hypoxic cortical laminar necrosis in a child with hemolytic anemia crisis
  488. Acute phase response in familial Mediterranean fever
  489. The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa
  490. A survey of phenotype II in familial Mediterranean fever
  491. Vasculitis in familial Mediterranean fever
  492. Picture of the Month
  493. C 30 Behçet's syndrome in childhood. A report of 44 patients
  494. Obesity and erythrocyte sedimentation rate in children
  495. PFAPA SYNDROME